134 related articles for article (PubMed ID: 16572038)
21. Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies.
Howell MR; Quinn TC; Gaydos CA
Ann Intern Med; 1998 Feb; 128(4):277-84. PubMed ID: 9471930
[TBL] [Abstract][Full Text] [Related]
22. Managing genital chlamydia trachomatis infection in Scotland: targeted opportunistic testing or a screening programme?
Clutterbuck DJ
Health Bull (Edinb); 2001 Nov; 59(6):396-404. PubMed ID: 12661390
[TBL] [Abstract][Full Text] [Related]
23. The Philadelphia High-School STD Screening Program: key insights from dynamic transmission modeling.
Fisman DN; Spain CV; Salmon ME; Goldberg M
Sex Transm Dis; 2008 Nov; 35(11 Suppl):S61-5. PubMed ID: 18607306
[TBL] [Abstract][Full Text] [Related]
24. Systematic screening for Chlamydia trachomatis: estimating cost-effectiveness using dynamic modeling and Dutch data.
de Vries R; van Bergen JE; de Jong-van den Berg LT; Postma MJ;
Value Health; 2006; 9(1):1-11. PubMed ID: 16441519
[TBL] [Abstract][Full Text] [Related]
25. The utility and cost of Chlamydia trachomatis and Neisseria gonorrhoeae screening of a male infertility population.
Domes T; Lo KC; Grober ED; Mullen JB; Mazzulli T; Jarvi K
Fertil Steril; 2012 Feb; 97(2):299-305. PubMed ID: 22192351
[TBL] [Abstract][Full Text] [Related]
26. Productivity losses attributable to untreated chlamydial infection and associated pelvic inflammatory disease in reproductive-aged women.
Blandford JM; Gift TL
Sex Transm Dis; 2006 Oct; 33(10 Suppl):S117-21. PubMed ID: 17003678
[TBL] [Abstract][Full Text] [Related]
27. Has the effectiveness of a single chlamydia test in preventing pelvic inflammatory disease over 12 months been overestimated?
Hay PE; Pittrof RU
Womens Health (Lond); 2010 Sep; 6(5):627-30. PubMed ID: 20887160
[No Abstract] [Full Text] [Related]
28. The cost effectiveness of opportunistic chlamydia screening in England.
Adams EJ; Turner KM; Edmunds WJ
Sex Transm Infect; 2007 Jul; 83(4):267-74; discussion 274-5. PubMed ID: 17475686
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of partner pharmacotherapy in screening women for asymptomatic infection with Chlamydia Trachomatis.
Postma MJ; Welte R; van den Hoek JA; van Doornum GJ; Jager HC; Coutinho RA
Value Health; 2001; 4(3):266-75. PubMed ID: 11705188
[TBL] [Abstract][Full Text] [Related]
30. Chlamydia trachomatis infections in female military recruits.
Gaydos CA; Howell MR; Pare B; Clark KL; Ellis DA; Hendrix RM; Gaydos JC; McKee KT; Quinn TC
N Engl J Med; 1998 Sep; 339(11):739-44. PubMed ID: 9731090
[TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness analysis of Chlamydia trachomatis screening in Dutch pregnant women.
Rours GI; Smith-Norowitz TA; Ditkowsky J; Hammerschlag MR; Verkooyen RP; de Groot R; Verbrugh HA; Postma MJ
Pathog Glob Health; 2016; 110(7-8):292-302. PubMed ID: 27958189
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of Chlamydia antibody tests in subfertile women.
Fiddelers AA; Land JA; Voss G; Kessels AG; Severens JL
Hum Reprod; 2005 Feb; 20(2):425-32. PubMed ID: 15539437
[TBL] [Abstract][Full Text] [Related]
33. [Chlamydia trachomatis: should it be systematically be screened or treated? Literature review and cost/benefit estimation in France].
Henry-Suchet J; Sluzhinska A; Serfaty D
Contracept Fertil Sex; 1998 Feb; 26(2):151-8. PubMed ID: 9560916
[TBL] [Abstract][Full Text] [Related]
34. Screening and treatment to prevent sequelae in women with Chlamydia trachomatis genital infection: how much do we know?
Gottlieb SL; Berman SM; Low N
J Infect Dis; 2010 Jun; 201 Suppl 2():S156-67. PubMed ID: 20470051
[TBL] [Abstract][Full Text] [Related]
35. Screening for Chlamydia trachomatis Infections in Women.
Wiesenfeld HC
N Engl J Med; 2017 Feb; 376(8):765-773. PubMed ID: 28225683
[No Abstract] [Full Text] [Related]
36. Cost and effectiveness of Chlamydia screening among male military recruits: Markov modeling of complications averted through notification of prior female partners.
Nevin RL; Shuping EE; Frick KD; Gaydos JC; Gaydos CA
Sex Transm Dis; 2008 Aug; 35(8):705-13. PubMed ID: 18461015
[TBL] [Abstract][Full Text] [Related]
37. A cost-effectiveness analysis of the Chlamydia Monday--a community-based intervention to decrease the prevalence of chlamydia in Sweden.
Deogan CL; Bocangel MK; Wamala SP; Månsdotter AM
Scand J Public Health; 2010 Mar; 38(2):141-50. PubMed ID: 20064921
[TBL] [Abstract][Full Text] [Related]
38. Universal screening or prophylactic treatment for Chlamydia trachomatis infection among women seeking induced abortions: which strategy is more cost-effective?
Chen S; Li J; van den Hoek A
Sex Transm Dis; 2007 Apr; 34(4):230-6. PubMed ID: 17414068
[TBL] [Abstract][Full Text] [Related]
39. [Opportunistic screening for genital infections with Chlamydia trachomatis among the sexually active population in Amsterdam. III. Cost-effectiveness analysis of screening women and the role of reinfection and partner treatment].
Postma MJ; Welte R; van den Hoek JA; Jager JC; van Doornum GJ; Coutinho RA
Ned Tijdschr Geneeskd; 1999 Nov; 143(47):2383-5. PubMed ID: 10590778
[TBL] [Abstract][Full Text] [Related]
40. Point-of-entry screening for C. trachomatis In female army recruits. Who derives the cost savings?
Howell MR; McKee KTJr ; Gaydos JC; Quinn TC; Gaydos CA
Am J Prev Med; 2000 Oct; 19(3):160-6. PubMed ID: 11020592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
